Trial
NCT07285369
High-Dose Ambroxol in Pediatric Type III Gaucher Disease (GD3)
UnknownTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Agyany Pharma LTD
Collaborators
—
Condition
Gaucher Disease, Type 3
Intervention
Ambroxol
Why stopped
Sponsor stopped the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-03